Physician

Li-Hong Lu, M.D.

According to 2025 Medicare claims, Li-Hong Lu, M.D. (NPI: 1497713861) practices physical medicine and rehabilitation in the Reading, PA market, with the plurality of this provider's patient population coming from Berks, PA. This provider's primary affiliated billing organization is TOWER HEALTH MEDICAL GROUP (NPI: 1114000726; TIN: 23-2266054) and primary practice location at 19610-1065.

Lu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 141 traditional Medicare patients, billed 43,253 HCPCS/CPT codes, and received $304,222 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 441 prescription claims across 89 beneficiaries totaling $36,182 in drug costs, led by Botox (Onabotulinumtoxina). 2018 DME data shows 12 claims. Open Payments data shows 2 records totaling $36. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $12,292 and ending at $36,182. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	284	25,379	$186,947
2016	248	29,976	$205,980
2017	254	29,045	$207,343
2018	244	27,657	$205,101
2019	209	28,049	$212,550
2020	188	27,108	$197,204
2021	158	27,893	$215,139
2022	199	26,619	$211,714
2023	116	35,241	$257,882
2024	141	43,253	$304,222

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	32	207	$12,292
2016	53	253	$21,699
2017	47	293	$32,569
2018	57	291	$55,045
2019	56	259	$40,068
2020	57	239	$26,899
2021	65	264	$30,944
2022	59	241	$13,131
2023	62	307	$22,036
2024	89	441	$36,182

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	12	$424
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	45	45	$119
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	64	231	$89
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	49	128	$66
95874	Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle	42	110	$55
J0585	Injection, onabotulinumtoxina, 1 unit	49	40,750	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Botox	Onabotulinumtoxina	15	1,326	$26,246
Dantrolene Sodium	Dantrolene Sodium	17	510	$1,768
Gabapentin	Gabapentin	88	3,480	$1,652
Baclofen	Baclofen	58	2,027	$1,610
Celecoxib	Celecoxib	15	450	$1,225

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$36	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Li-Hong Lu, M.D.?

Tedicare shows public-source Medicare data for Li-Hong Lu, M.D. (NPI 1497713861), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Li-Hong Lu, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Li-Hong Lu, M.D.?

Li-Hong Lu, M.D. is linked to TOWER HEALTH MEDICAL GROUP (billing NPI 1114000726) in the available physician profile data.

Does Li-Hong Lu, M.D. have Open Payments data?

Li-Hong Lu, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.